Clinical Trials Logo

Clinical Trial Summary

The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06263998
Study type Interventional
Source Huons Co., Ltd.
Contact SUNGGUK CHO
Phone +82-02-854-4700
Email sgcho@huons.com
Status Not yet recruiting
Phase Phase 1
Start date June 3, 2024
Completion date January 30, 2026

See also
  Status Clinical Trial Phase
Withdrawn NCT04636372 - Effect of Meibomian Gland Related Therapy on the Morphology of Meibomian Gland N/A
Completed NCT03753893 - Ocular Manifestations in Rheumatic Diseases
Completed NCT01089985 - Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye Phase 1
Completed NCT00796926 - Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes Phase 3
Withdrawn NCT02655432 - Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population Phase 0
Recruiting NCT04877483 - To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome N/A
Completed NCT05656196 - VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's Syndrome N/A